{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:54:21Z","timestamp":1792853661171,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ad.2019.12.006","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T10:48:32Z","timestamp":1589366912000},"page":"561-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Doxiciclina, \u00bfantibi\u00f3tico o antiinflamatorio? Usos m\u00e1s frecuentes en dermatolog\u00eda"],"prefix":"10.1016","volume":"111","author":[{"given":"F.J.","family":"Navarro-Trivi\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2019.12.006_bib0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","article-title":"Aureomycin; a product of the continuing search for new antibiotics","volume":"51","author":"Duggar","year":"1948","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ad.2019.12.006_bib0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.11.3.462","article-title":"Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects","volume":"11","author":"Welling","year":"1977","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.ad.2019.12.006_bib0190","first-page":"407","article-title":"Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells","volume":"125","author":"Fife","year":"1995","journal-title":"J Lab clin Med"},{"key":"10.1016\/j.ad.2019.12.006_bib0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv Den Res"},{"key":"10.1016\/j.ad.2019.12.006_bib0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0765.2004.00696.x","article-title":"Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis","volume":"39","author":"Choi","year":"2004","journal-title":"J Periodontal Res."},{"key":"10.1016\/j.ad.2019.12.006_bib0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1097-4644(19960301)60:3<341::AID-JCB6>3.0.CO;2-W","article-title":"Transcriptional downregulation of stromelysin by tetracycline","volume":"60","author":"Jonat","year":"1996","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ad.2019.12.006_bib0210","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/AAC.01540-08","article-title":"Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes","volume":"53","author":"Ishikawa","year":"2009","journal-title":"Antimicrob Agents Chemoter"},{"key":"10.1016\/j.ad.2019.12.006_bib0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/01902140600691399","article-title":"Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells","volume":"32","author":"Raza","year":"2006","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.ad.2019.12.006_bib0220","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1099800409346333","article-title":"The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds","volume":"11","author":"Stechmiller","year":"2010","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.ad.2019.12.006_bib0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2014.08.001","article-title":"Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxis","volume":"91","author":"Su","year":"2014","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.ad.2019.12.006_bib0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10715769709097783","article-title":"Prevention of perixynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics","volume":"26","author":"Whiteman","year":"1997","journal-title":"Free Radic Res"},{"key":"10.1016\/j.ad.2019.12.006_bib0235","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"Am Acad Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ad.2019.01.001","article-title":"Documento de consenso espa\u00f1ol para el algoritmo de tratamiento de la ros\u00e1cea","author":"Salleras","year":"2019","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.12.006_bib0245","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.mayocp.2015.08.020","article-title":"Hidradenitis suppurativa: A guide for the practicing physician","volume":"90","author":"Woodruff","year":"2015","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.ad.2019.12.006_bib0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.ad.2019.12.006_bib0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ad.2017.09.007","article-title":"Doxycycline, a well-tolerated, economic, and effective alternative for the first-line treatment of bullous pemphigoid","volume":"109","author":"Morgado-Carrasco","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.12.006_bib0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40257-014-0067-7","article-title":"Perioral dermatitis: A review of the condition with special attention to treatment options","volume":"15","author":"Tempark","year":"2014","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0265","first-page":"179","article-title":"Perioral dermatitis: Still a therapeutic challenge","volume":"54","author":"Bukvi\u0107 Mokos","year":"2015","journal-title":"Acta Clin Croat."},{"key":"10.1016\/j.ad.2019.12.006_bib0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet syndrome: A review and update","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.12.006_bib0275","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jfma.2016.12.001","article-title":"A case of Sweet syndrome successfully treated by anti-inflammatory property of doxycycline","volume":"116","author":"Liaw","year":"2017","journal-title":"J Formos Med Assoc."},{"key":"10.1016\/j.ad.2019.12.006_bib0355","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00042728-200504000-00022","article-title":"Successful treatment of granulomatous reactions secondary to injection of esthetic implants","volume":"31","author":"Lloret","year":"2005","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.ad.2019.12.006_bib0360","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1468-3083.2008.02707.x","article-title":"Generalized granuloma annulare: Response to doxycycline","volume":"23","author":"Duarte","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2019.12.006_bib0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-016-0583-y","article-title":"SAPHO syndrome: Current developments and approaches to clinical treatment","volume":"18","author":"Firinu","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ad.2019.12.006_bib0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdcr.2015.12.002","article-title":"Successful treatment of bacillary angiomatosis with oral doxycycline in an HIV-infected child with skin lesions mimicking Kaposi sarcoma","volume":"2","author":"Rodriguez","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ad.2019.12.006_bib0305","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: An AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2019.12.006_bib0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: Nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-4632.2010.04625.x","article-title":"Prurigo pigmentosa: A clinicopathological study and analysis of associated factors","volume":"50","author":"Lu","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2019.12.006_bib0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.annder.2018.12.006","article-title":"Prurigo pigmentosa in a fair-skinned European woman: Dramatic improvement with doxycycline","volume":"146","author":"Sanchez","year":"2019","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.ad.2019.12.006_bib0325","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/1346-8138.13307","article-title":"Pustular prurigo pigmentosa treated with doxycycline","volume":"43","author":"Kim","year":"2016","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1468-3083.2011.04090.x","article-title":"Doxycycline: An emerging therapy for prurigo pigmentosa","volume":"26","author":"Mok","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2019.12.006_bib0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjd.14820","article-title":"Patients with chronic cold urticaria may benefit from doxycycline therapy","volume":"176","author":"Gorczyza","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0340","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/000155502320624249","article-title":"Successful treatment of acquired reactive perforating collagenosis with doxycycline","volume":"82","author":"Brinkmeier","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2019.12.006_bib0345","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1365-4632.2006.02947.x","article-title":"Two cases of acquired perforating dermatosis treated with doxycycline therapy","volume":"45","author":"G\u00f6n\u00fcl","year":"2006","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2019.12.006_bib0350","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13022","article-title":"Doxycycline: An option in the treatment of ulcerated oral lesions?","author":"Piacentini","year":"2019","journal-title":"J Clin Pharm Ther."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020301265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020301265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:10:34Z","timestamp":1757553034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731020301265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0001731020301265"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2019.12.006","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxiciclina, \u00bfantibi\u00f3tico o antiinflamatorio? Usos m\u00e1s frecuentes en dermatolog\u00eda","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}